TrialThe Journal of clinical investigation2022

Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months.

Magdalena E Sobieszczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.